Addison Advisors LLC Adma Biologics, Inc. Transaction History
Addison Advisors LLC
- $340 Million
- Q3 2024
A detailed history of Addison Advisors LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Addison Advisors LLC holds 500 shares of ADMA stock, worth $8,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$8,745
Previous $5,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$326 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$317 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$227 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$221 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$150 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.43B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...